Clinical Diagnostics and Research Tools

  1. 20 Mar 2019  |  North America

    Growth Opportunities in the North American Clinical Laboratory Services Market, Forecast to 2022

    Laboratories Seek Alternate Revenue Streams to Combat Reimbursement Pressure

    Clinical laboratory services represent one of the highest healthcare expenditures in North America, yet the United States and Canada represent different scenarios in the way clinical services are rendered. The market for clinical lab services in Canada was an estimated $10.33 billion in 2017 whereas in the United States it was an estimated $78.33 b...

    $4,950.00
  2. 20 Mar 2019  |  North America

    2019 Predictions of the Global Life Sciences Industry

    As Novel Technologies Find Traction, Industry Focus Will Shift Towards Successful Monetization to Deliver Value-based Care

    he global life science industry is in a state of flux. While the recent years have seen the advent of multiple novel technologies, such as in-vitro diagnostics (IVD), CRISPR-Cas9, virtual clinical trials, and liquid biopsy, the industry stands at a crossroad with challenges in scaling-up and commercializing such technologies. In addition, companies...

    $1,500.00
  3. 11 Feb 2019  |  North America

    Global Laboratory Products Purchasing Trends, 2018–2019

    An End-user Perspective on Laboratory Spending Reveals Modest 2019 Budget Increases Following Healthier 2018 Spending

    Readers of one of Frost & Sullivan’s media partners were invited to participate in an online survey in September 2018 that centered around the state of their laboratories in 2018 and their expectations for 2019. Frost & Sullivan has conducted similar studies among the same targeted respondents since 2012. Where applicable, the study presents year...

    $1,500.00
  4. 14 Jan 2019  |  North America

    Growth Opportunities in the Global qPCR and dPCR Market, Forecast to 2023

    Novel Applications in Oncology and Applied Sciences, Growing Research and Diagnostic Use in Developing Regions, and Automated Modular Workflows to Drive Growth

    Overview: PCR continues to be the gold standard for nucleic acid amplification by combining accuracy and efficacy that users across areas such as research, pharma & biotech, diagnostics as well as applied sciences depend upon. Such widespread usage continues to drive the industry, even protecting it to some extent from overall economic/market fluct...

    $4,950.00
  5. 12 Dec 2018  |  North America

    Growth Opportunities in Functional Consumables Aftermarket, Forecast to 2023

    Innovation-as-a-service Business Model will Accelerate Growth in the Molecular Diagnostic Subsegment

    Rapid technological turnaround has become a norm in the life science and in-vitro diagnostic industry. Extrinsic factors such as lack of skilled labor to operate the instrumentation as well as functional factors like demand for very high precision and reproducibility of results are driving this technological evolution. As the instrument efficiency ...

    $4,950.00
  6. 22 Oct 2018  |  North America

    Global Life Sciences Instrumentation and Research Tools Market, Forecast to 2023

    Digitalization and M&As to Transform the Current Competitive Structure of the Industry

    The global life sciences instrumentation and research tools market is currently going through a transformation driven by ongoing market consolidation and technological innovation. Over the past five years, the industry has witnessed more than 50 mergers and acquisitions (M&A), which have resulted in a market consolidation at the top. Most of these ...

    $4,950.00
  7. 05 Oct 2018  |  North America

    US Point-of-Care Testing Infectious Disease Market, Forecast to 2022

    CLIA Waived Molecular POCT, Coupled with Upcoming Diseases Like Sepsis, Lyme Disease, New Strains of Influenza—H1, H3, and H7, will Drive Growth

    Management of infectious diseases remains a critical challenge for public health professionals who face increasing demand to control the spread of existing and novel diseases. To provide appropriate healthcare assistance, it is imperative to diagnose the exact form of infection from an array of complicated symptoms expressed by the host. As the out...

    $1,500.00
  8. 04 Sep 2018  |  North America

    Digital Transformation in the Pharmaceuticals Industry—Companies-to-Action, 2018

    Value-based Care, Patient Data Digitization, and Collaborative Technology Deployment Offer Investment Opportunities

    The pharmaceutical industry today is in a state of flux as it tries to maintain a delicate balance between the need for novel blockbuster drugs and the need for improved operational efficiencies in an increasingly competitive market space. As healthcare is becoming increasingly democratized, patients are emerging as key decision makers—digitally ...

    $3,000.00
  9. 27 Aug 2018  |  Global

    Growth Insights for the Direct-to-Consumer Genetic Testing Market, Forecast to 2022

    Consumer Education and Exploring Alternative Markets Would Drive the Direct-to-Consumer Genetic Testing Market

    As healthcare evolves toward personalized solutions, everyday consumers are proactively taking responsibility for their health in ways unimaginable a decade ago. A direct-to-consumer genetic test (DTCGT) exemplifies this trend which can be purchased and used directly by consumers without the requirement of a prescription from a healthcare provider....

    $3,000.00
  10. 23 Aug 2018  |  Europe

    Western European Clinical Laboratory Services Market, Forecast to 2022

    Clinical Labs to Transform into Health Information Companies and Increasingly Participate in Clinical Decision Support

    Diagnostics has inarguably become an integral part of healthcare system, moving from reactionary science to predictive science; playing a vital role throughout the care continuum. While rising burden of chronic diseases, drug-resistant diseases and the increasing proportion of elderly population are the organic growth drivers, the shift towards cre...

    $4,950.00